The Rockefeller University
Virtual Discussions with Genuine Experts
December 10, 2020
Richard P. Lifton, M.D., Ph.D.
President and Carson Family Professor
Laboratory of Human Genetics and Genomics
The Rockefeller University
Michel C. Nussenzweig, M.D., Ph.D.
Zanvil A. Cohn and Ralph M. Steinman Professor
Laboratory of Molecular Immunology
Investigator, Howard Hughes Medical Institute
The Rockefeller University
Since the onset of the pandemic, immunologist Michel Nussenzweig has been working to deliver new antibody treatments for COVID-19. In this webinar, Dr. Nussenzweig and President Rick Lifton discussed some of the most pressing questions about COVID-19 research and therapeutic discovery. For example, “What is the status of antibody therapies developed at Rockefeller?” and “Can antibody therapies protect against infection?”
Your contributions are vital to COVID-19 research.
To learn more about research at Rockefeller University and to make a gift to the Fund for COVID-19 Research please visit:
